Cutler Group’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-450
Closed -$24.7K 5833
2022
Q1
$32K Buy
+450
New +$32.4K ﹤0.01% 2650
2021
Q4
Sell
-1,450
Closed -$145K 6277
2021
Q3
$168K Buy
1,450
+870
+150% +$114K 0.01% 1495
2021
Q2
$96K Sell
580
-640
-52% -$99.9K ﹤0.01% 1923
2021
Q1
$170K Buy
1,220
+669
+121% +$109K 0.01% 1389
2020
Q4
$95K Buy
+551
New +$89.2K ﹤0.01% 1569
2020
Q1
Sell
-500
Closed -$60.1K 4798
2019
Q4
$58K Buy
500
+200
+67% +$19.8K ﹤0.01% 1536
2019
Q3
$25K Sell
300
-1,800
-86% -$136K ﹤0.01% 2038
2019
Q2
$136K Buy
+2,100
New +$131K 0.01% 928
2018
Q4
Sell
-921
Closed -$40.9K 4724
2018
Q3
$52K Sell
921
-7,025
-88% -$439K ﹤0.01% 1596
2018
Q2
$634K Buy
+7,946
New +$659K 0.05% 371
2018
Q1
Sell
-3,718
Closed -$300K 5379
2017
Q4
$256K Sell
3,718
-4,378
-54% -$350K 0.01% 832
2017
Q3
$735K Sell
8,096
-14,779
-65% -$1.27M 0.03% 461
2017
Q2
$1.7M Buy
22,875
+16,179
+242% +$1.3M 0.06% 253
2017
Q1
$627K Buy
6,696
+5,334
+392% +$483K 0.03% 554
2016
Q4
$98K Buy
1,362
+556
+69% +$47.6K ﹤0.01% 1934
2016
Q3
$84K Sell
806
-6,308
-89% -$570K ﹤0.01% 1960
2016
Q2
$524K Sell
7,114
-6,334
-47% -$430K 0.03% 564
2016
Q1
$756K Buy
13,448
+9,181
+215% +$542K 0.05% 350
2015
Q4
$288K Buy
+4,267
New +$228K 0.02% 911

Other funds holding NVRO

Cutler Group's NVRO Position: Q2 2022 in Review

Cutler Group sold out of NEVRO CORP. (NVRO) in Q2 2022, closing a stake of 450 shares — an estimated $24.7K sold.

Cutler Group first reported a position in NVRO in Q4 2015 and held it in 19 quarters. The position peaked at $1.7M in Q2 2017. 175 funds tracked by Wall St. Rank hold NVRO as of Q2 2022.

  • Cutler Group reported no remaining NEVRO CORP. position as of Q2 2022 after selling out during the quarter.
  • Cutler Group sold 450 NEVRO CORP. shares in Q2 2022, an estimated $24.7K.
  • Cutler Group first reported a position in NEVRO CORP. in Q4 2015 and held it in 19 quarters.
  • Cutler Group's NEVRO CORP. position peaked at $1.7M in Q2 2017.
  • 175 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2022.

Based on Cutler Group's 13F filing for Q2 2022, filed 4 Aug 2022.